Skip to content

Understanding How Treatment Affects Biological Changes Associated with Suicidal Behaviour

Epigenetic Correlation of the Candidate Genes in Brain Tissue and Blood of Suicide Completers: Validation in suicidality and to evaluate the epigenetic changes following intervention - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112136
Enrollment
22
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhere

Interventions

Intervention1: COGNITIVE BEHAVIOURAL THERAPY: Admission of Cognitive Behavioural Therapy (8-10 sessions) to the recent suicide attempter/ideators (up to 14 days), which fits in the inclusion criteria
instead, they will be under treatment as usual. These will work as controls for the patients who will be given treatment as usual with CBT so that we can monitor the effect of CBT on epigenetics.

Sponsors

ICMR task force AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: History of recent suicide attempt/ current suicidal ideation, without considering whether suicidal behavior was or was not the immediate reason for hospitalization (14 days). If the participant can communicate verbally or in writing in Hindi/English. The participants must be an India citizen descending from Indian parents and grandparents.

Exclusion criteria

Exclusion criteria: History of any chronic inflammatory disease like asthma, cancer, hepatitis, cirrhosis etc. History of medication (medications taken in last 2 months for any chronic illness) History of drug abuse including alcohol (addiction, or intoxicated at the time of suicide attempt). Subjects will be excluded if their self-injurious behaviors determined to have no suicidal Intention or ideation. Patient/ Family members/legal guardian not giving consent Patients with imminent risk of suicide Acute psychosis Acute Mania Severe Cognitive Impairment Emotional dysregulation too severe to process therapy

Design outcomes

Primary

MeasureTime frame
Change in severity of suicidal ideation measured by the Columbia Suicide Severity Rating Scale (CSSRS),Difficulty in Emotional Regulation (DERS), Barrat Impulsivity Scale (BIS), Hospital Anxiety and Depression Scale (HADS) from baseline to 3 months after CBT intervention. The healing effect due to the administration of CBT will be monitored by checking the methylation levels of certain Differentially Methylated Regions of 10 genes which are linked to suicidal behavior.Timepoint: base line, 3 months, 6 months. Blood from the patient will be collected at baseline (after the recent suicide attempt/ideation). Then the patient will be given CBT(10 sessions) and blood will be taken at 3 months to check the effect of CBT on epigenetics. 6 month blood collection would be taken to check the stability of the biomarkers.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactBhival Nishad

All India Institute of Medical Sciences, New Delhi

drchitta75@rediffmail.com9968320486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026